SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Q1 2024 Earnings Call Transcript
Operator: Good morning. My name is Tawanda, and I will be your conference operator today.
Springworks Therapeutics Inc. (SWTX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 3,479,853 | $171,278,365 | -15% | 4.9% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,966,622 | $146,017,134 | -2% | 0.22% |
| 3. | Perceptive Advisors Joseph Edelman | 2,262,462 | $111,358,380 | +16% | 1.93% |
| 4. | Maverick Capital Lee Ainslie | 1,908,630 | $93,942,769 | -34% | 1.76% |
| 5. | OrbiMed Advisors Samuel Isaly | 1,707,331 | $84,034,832 | -47% | 1.53% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 50,000 | Large Shareholder, Director | 4,593,847 | 2019-09-17 | Filing | |
| $18.00 | 275,000 | Large Shareholder, Director | 7,406,307 | 2019-09-17 | Filing | |
| $18.00 | 275,000 | Large Shareholder | 7,406,307 | 2019-09-17 | Filing | |
| $18.00 | 150,000 | Large Shareholder | 7,281,307 | 2019-09-17 | Filing | |
| $18.00 | 50,000 | Large Shareholder | 4,593,847 | 2019-09-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $42.09 | 400 | Officer, Director | 1,112,368 | 2024-06-03 | Filing | |
| $41.40 | 6,600 | Officer, Director | 1,112,768 | 2024-06-03 | Filing | |
| $40.57 | 8,760 | Officer, Director | 1,119,368 | 2024-06-03 | Filing | |
| $39.40 | 33,240 | Officer, Director | 1,128,128 | 2024-06-03 | Filing | |
| $42.09 | 20 | Director | 4,095 | 2024-06-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,809,235 | $394,537,078 | 0.03% | |
| 2. | 6,036,542 | $220,333,783 | 0% | |
| 3. | 5,382,184 | $196,449,717 | 0% | |
| 4. | 3,421,541 | $124,886,247 | 6.22% | |
| 5. | 2,619,650 | $95,617,225 | 0% |
News See All
12 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the 12 most promising cancer stocks according to analysts.
11 Best High Short Interest Stocks To Buy Now
In this piece, we will take a look at the 11 best high short interest stocks to buy now.
Bank of America's 15 Stock Picks for 2023
2023 is turning out to be an interesting year for the stock market.
Top 5 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying
Below we present the list of the top 5 healthcare stocks the experts at Sphera Global Healthcare Fund are buying.
8 Medical Stocks to Buy According to Mitchell Blutt's Consonance Capital
In this article, we will be looking at the 8 medical stocks to buy according to Mitchell Blutt's Consonance Capital.
Top 5 Stock Picks of Samuel Isaly's OrbiMed Advisors
In this article, we will discuss the top 5 stock picks of Samuel Isaly's OrbiMed Advisors.
SpringWorks Therapeutics, Inc. (SWTX): Hedge Funds Are Snapping Up
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
5 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors
In this article, we will discuss the 5 best biotech stocks to buy according to Joseph Edelman's Perceptive Advisors based on Q2 holdings of the fund.
15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Billionaire Hedge Funds
